Location History:
- Planegg, DE (2010 - 2020)
- Ludwigshafen, DE (2020)
Company Filing History:
3 out of 50 
1 out of 44 
1 out of 36 
Years Active: 2010-2020
Title: Philippe Thiel: Innovator in Tumor Diagnosis and Therapy
Introduction
Philippe Thiel is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of tumor diagnosis and therapy, holding a total of 6 patents. His work focuses on the identification of gene products associated with tumors and the development of therapeutic methods.
Latest Patents
One of his latest patents is titled "Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy." This invention pertains to the identification of gene products resulting from tumor-associated expression, as well as the nucleic acids encoding these products. It also addresses the therapy and diagnosis of diseases linked to aberrant tumor-associated expression. Another significant patent is "Antibodies against notch 3," which relates to antibodies or fragments that target conformational epitopes of the Notch 3 receptor, including its mutant forms. This patent includes compositions and methods for their use.
Career Highlights
Philippe Thiel has worked with several prominent organizations, including Ganymed Pharmaceuticals AG and Johannes Gutenberg-Universität Mainz. His career reflects a strong commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Philippe has collaborated with notable professionals in the field, including Ugur Sahin and Dirk Usener. These collaborations have further enhanced his contributions to tumor research and therapy.
Conclusion
Philippe Thiel's work in the field of tumor diagnosis and therapy exemplifies the impact of innovation in medical science. His patents and collaborations highlight his dedication to improving healthcare outcomes through research and development.